{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:00:00Z","timestamp":1747173600895,"version":"3.40.5"},"reference-count":98,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aim to assess the relationship between validated smoking cessation pharmacotherapies and electronic cigarettes (e-cigarettes) and insomnia and parasomnia using a systematic review and a network meta-analysis. A systematic search was performed until August 2022 in the following databases: PUBMED, COCHRANE, CLINICALTRIAL. Randomized controlled studies against placebo or validated therapeutic smoking cessation methods and e-cigarettes in adult smokers without unstable or psychiatric comorbidity were included. The primary outcome was the presence of \u201cinsomnia\u201d and \u201cparasomnia.\u201d A total of 1261 studies were selected. Thirty-seven studies were included in the quantitative analysis (34 for insomnia and 23 for parasomnia). The reported interventions were varenicline (23 studies), nicotine replacement therapy (NRT, 10 studies), bupropion (15 studies). No studies on e-cigarettes were included. Bayesian analyses found that insomnia and parasomnia are more frequent with smoking cessation therapies than placebo except for bupropion. Insomnia was less frequent with nicotine substitutes but more frequent with bupropion than the over pharmacotherapies. Parasomnia are less frequent with bupropion but more frequent with varenicline than the over pharmacotherapies. Validated smoking cessation pharmacotherapies can induce sleep disturbances with different degrees of frequency. Our network meta-analysis shows a more favorable profile of nicotine substitutes for insomnia and bupropion for parasomnia. It seems essential to systematize the assessment of sleep disturbances in the initiation of smoking cessation treatment. This could help professionals to personalize the choice of treatment according to sleep parameters of each patient. Considering co-addictions, broadening the populations studied and standardizing the measurement are additional avenues for future research.<\/jats:p>","DOI":"10.1017\/s1092852924000087","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T07:58:23Z","timestamp":1709539103000},"page":"96-108","source":"Crossref","is-referenced-by-count":0,"title":["Insomnia and parasomnia induced by validated smoking cessation pharmacotherapies and electronic cigarettes: a network meta-analysis"],"prefix":"10.1017","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3603-5710","authenticated-orcid":false,"given":"Paul","family":"Vanderkam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Pomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Palina","family":"Dzeraviashka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Castera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nematollah","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Lafay-Chebassier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2024,3,4]]},"reference":[{"key":"S1092852924000087_r29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","article-title":"International classification of sleep disorders-third edition: highlights and modifications","volume":"146","author":"Sateia","year":"2014","journal-title":"Chest."},{"key":"S1092852924000087_r44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.clinthera.2011.04.013","article-title":"Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study","volume":"33","author":"Bolliger","year":"2011","journal-title":"Clin Ther."},{"key":"S1092852924000087_r78","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00002018-199920060-00007","article-title":"Predictors and timing of adverse experiences during trandsdermal nicotine therapy","volume":"20","author":"Gourlay","year":"1999","journal-title":"Drug Saf."},{"key":"S1092852924000087_r65","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5694\/j.1326-5377.1994.tb127344.x","article-title":"The transdermal nicotine patch: results of a randomised placebo-controlled trial","volume":"161","author":"Richmond","year":"1994","journal-title":"Med J Aust."},{"key":"S1092852924000087_r37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jrsm.1373","article-title":"MetaInsight: an interactive web-based tool for analyzing, interrogating, and visualizing network meta-analyses using R-shiny and netmeta","volume":"10","author":"Owen","year":"2019","journal-title":"Res Syn Meth."},{"key":"S1092852924000087_r9","first-page":"CD000146","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"5","author":"Hartmann\u2010Boyce","year":"2018","journal-title":"Cochrane Database Syst Rev."},{"key":"S1092852924000087_r67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1753465809350653","article-title":"Effectiveness of pharmacotherapy and behavioral interventions for smoking cessation in actual clinical practice","volume":"3","author":"Rovina","year":"2009","journal-title":"Ther Adv Respir Dis."},{"volume-title":"Relapse Prevention: Maintenance Strategies in the Treatment of Addictive Behaviors","year":"2005","author":"Marlatt","key":"S1092852924000087_r11"},{"key":"S1092852924000087_r22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0006-8993(00)03104-8","article-title":"Subcutaneous administration of nicotine changes dorsal raphe serotonergic neurons discharge rate during REM sleep","volume":"888","author":"Guzm\u00e1n-Mar\u00edn","year":"2001","journal-title":"Brain Res."},{"key":"S1092852924000087_r42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta22410","article-title":"Nicotine preloading for smoking cessation: the preloading RCT","volume":"22","author":"Aveyard","year":"2018","journal-title":"Health Technol Assess."},{"key":"S1092852924000087_r74","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.4088\/JCP.11m07522","article-title":"A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder","volume":"73","author":"Williams","year":"2012","journal-title":"J Clin Psychiatry."},{"key":"S1092852924000087_r19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/pubmed\/fdx102","article-title":"Tobacco exposure and sleep disturbance in 498 208 UK Biobank participants","volume":"40","author":"Boakye","year":"2018","journal-title":"J Public Health (Oxf)."},{"key":"S1092852924000087_r90","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1360-0443.2007.01822.x","article-title":"The impact of pharmaceutical company funding on results of randomised trials of nicotine replacement therapy for smoking cessation: a meta-analysis","volume":"102","author":"Etter","year":"2007","journal-title":"Addiction."},{"key":"S1092852924000087_r50","doi-asserted-by":"crossref","first-page":"c6549","DOI":"10.1136\/bmj.c6549","article-title":"Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial","volume":"341","author":"Fagerstr\u00f6m","year":"2010","journal-title":"BMJ."},{"key":"S1092852924000087_r58","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199903043400903","article-title":"A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation","volume":"340","author":"Jorenby","year":"1999","journal-title":"N Engl J Med."},{"key":"S1092852924000087_r23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0924-977X(01)00104-3","article-title":"Nicotine stimulation of dorsal raphe neurons: effects on laterodorsal and pedunculopontine neurons","volume":"11","author":"Mihailescu","year":"2001","journal-title":"Eur Neuropsychopharmacol."},{"key":"S1092852924000087_r28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0306-4603(85)90034-6","article-title":"Reports of smoking withdrawal symptoms over a 21 day period of abstinence","volume":"10","author":"Cummings","year":"1985","journal-title":"Addict Behav."},{"key":"S1092852924000087_r21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1037\/a0023128","article-title":"Effect of night smoking, sleep disturbance, and their co-occurrence on smoking outcomes","volume":"25","author":"Peters","year":"2011","journal-title":"Psychol Addict Behav."},{"key":"S1092852924000087_r82","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.physbeh.2006.04.009","article-title":"The effect of transdermal nicotine patches on sleep and dreams","volume":"88","author":"Page","year":"2006","journal-title":"Physiol Behav."},{"key":"S1092852924000087_r5","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/postgradmedj-2014-133193","article-title":"The effectiveness of tobacco control policies on vulnerable populations in the USA: a review","volume":"92","author":"Vijayaraghavan","year":"2016","journal-title":"Postgrad Med J."},{"key":"S1092852924000087_r12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/j.1742-1241.2011.02758.x","article-title":"Smoking, smoking cessation and smoking relapse patterns: a web-based survey of current and former smokers in the US","volume":"65","author":"Yeomans","year":"2011","journal-title":"Int J Clin Pract."},{"key":"S1092852924000087_r26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/ntr\/ntx236","article-title":"Sleep as a target for optimized response to smoking cessation treatment","volume":"21","author":"Patterson","year":"2017","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r48","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ntr\/ntt097","article-title":"A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users","volume":"15","author":"Ebbert","year":"2013","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1017\/jsc.2016.11","article-title":"Sleep disturbance during smoking cessation: withdrawal or side effect of treatment?","volume":"12","author":"Ashare","year":"2017","journal-title":"J Smok Cessat."},{"key":"S1092852924000087_r1","unstructured":"1. Tobacco. World Health Organization. [Internet]. https:\/\/www.who.int\/fr\/news-room\/fact-sheets\/detail\/tobacco."},{"key":"S1092852924000087_r18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/aje\/kwj231","article-title":"Cigarette smoking and nocturnal sleep architecture","volume":"164","author":"Zhang","year":"2006","journal-title":"Am J Epidemiol."},{"key":"S1092852924000087_r45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jamapsychiatry.2013.678","article-title":"Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal","volume":"70","author":"Cinciripini","year":"2013","journal-title":"JAMA Psychiatry."},{"key":"S1092852924000087_r62","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archinte.166.15.1561","article-title":"Smoking cessation with varenicline, a selective \u03b14\u03b22 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up","volume":"166","author":"Nides","year":"2006","journal-title":"Arch Intern Med."},{"key":"S1092852924000087_r24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1523\/JNEUROSCI.0232-03.2004","article-title":"Nicotinic enhancement of the noradrenergic inhibition of sleep-promoting neurons in the ventrolateral preoptic area","volume":"24","author":"Saint-Mleux","year":"2004","journal-title":"J Neurosci."},{"key":"S1092852924000087_r57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"JAMA."},{"key":"S1092852924000087_r72","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1253\/circj.CJ-09-0803","article-title":"A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers - efficacy, safety and withdrawal symptoms (the VN-SEESAW study)","volume":"74","author":"Tsukahara","year":"2010","journal-title":"Circ J."},{"key":"S1092852924000087_r3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"5","author":"Degenhardt","year":"2018","journal-title":"Lancet Psychiatry."},{"key":"S1092852924000087_r17","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ntr\/nty230","article-title":"Evidence for genetic correlations and bidirectional, causal effects between smoking and sleep behaviors","volume":"21","author":"Gibson","year":"2018","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r60","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14622200801968343","article-title":"A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling","volume":"10","author":"McCarthy","year":"2008","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r64","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/ntr\/ntr220","article-title":"A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates","volume":"14","author":"Rennard","year":"2012","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/thx.2004.030239","article-title":"Efficacy of bupropion in the indigenous Maori population in New Zealand","volume":"60","author":"Holt","year":"2005","journal-title":"Thorax."},{"key":"S1092852924000087_r20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1186\/s12889-019-6929-4","article-title":"Sleep quality in cigarette smokers and nonsmokers: findings from the general population in central China","volume":"19","author":"Liao","year":"2019","journal-title":"BMC Public Health."},{"key":"S1092852924000087_r35","unstructured":"35. Covidence Systematic Review Software, Veritas Health Innovation, Melbourne, Australia [Internet]. www.covidence.org."},{"key":"S1092852924000087_r73","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1440-1843.2008.01476.x","article-title":"Varenicline for smoking cessation: a placebo-controlled, randomized study","volume":"14","author":"Wang","year":"2009","journal-title":"Respirology."},{"key":"S1092852924000087_r46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14622200310001656867","article-title":"A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees","volume":"6","author":"Dalsgar\u00f0","year":"2004","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r81","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(96)00921-3","article-title":"Transdermal nicotine on sleep and PGO spikes","volume":"737","author":"Vazquez","year":"1996","journal-title":"Brain Res."},{"key":"S1092852924000087_r51","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/archinte.167.16.1791","article-title":"A double-blind, placebo-controlled, randomized trial of bupropion for smoking cessation in primary care","volume":"167","author":"Fossati","year":"2007","journal-title":"Arch Intern Med."},{"key":"S1092852924000087_r32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol."},{"key":"S1092852924000087_r30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res."},{"key":"S1092852924000087_r84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00213-007-1041-3","article-title":"Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt","volume":"197","author":"West","year":"2008","journal-title":"Psychopharmacology."},{"key":"S1092852924000087_r52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/clpt.2014.124","article-title":"Retreatment with varenicline for smoking cessation in smokers who have previously taken varenicline: a randomized, placebo-controlled trial","volume":"96","author":"Gonzales","year":"2014","journal-title":"Clin Pharmacol Ther."},{"key":"S1092852924000087_r83","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.sleep.2005.09.008","article-title":"Sleep effects of a 24-h versus a 16-h nicotine patch: a polysomnographic study during smoking cessation","volume":"7","author":"Staner","year":"2006","journal-title":"Sleep Med."},{"key":"S1092852924000087_r2","unstructured":"2. World Health Organization, Management of Substance Abuse Team, World Health Organization. Global Status Report on Alcohol and Health; 2018. http:\/\/www.who.int\/substance_abuse\/publications\/global_alcohol_report\/en\/."},{"key":"S1092852924000087_r43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2015.19284","article-title":"Effects of nicotine patch vs varenicline vs combination nicotine replacement therapy on smoking cessation at 26 weeks: a randomized clinical trial","volume":"315","author":"Baker","year":"2016","journal-title":"JAMA."},{"key":"S1092852924000087_r4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.rmr.2011.09.048","article-title":"Smoking cessation in \u201cdifficult smokers","volume":"29","author":"Perriot","year":"2012","journal-title":"Revue des maladies respiratoires"},{"key":"S1092852924000087_r39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1001\/jama.288.4.468","article-title":"Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial","volume":"288","author":"Ahluwalia","year":"2002","journal-title":"JAMA."},{"key":"S1092852924000087_r54","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pupt.2005.05.003","article-title":"A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results","volume":"19","author":"Haggstr\u00e4m","year":"2006","journal-title":"Pulm Pharmacol Ther."},{"key":"S1092852924000087_r79","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF02246542","article-title":"High dose transdermal nicotine therapy for heavy smokers: safety, tolerability and measurement of nicotine and cotinine levels","volume":"122","author":"Fredrickson","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"S1092852924000087_r86","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1007\/s004150170026","article-title":"The association of dopamine agonists with daytime sleepiness, sleep problems and quality of life in patients with Parkinson\u2019s disease","volume":"248","author":"Happe","year":"2001","journal-title":"J Neurol."},{"key":"S1092852924000087_r94","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1617-9625-8-8","article-title":"Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals","volume":"8","author":"Mills","year":"2010","journal-title":"Tob Induced Dis."},{"key":"S1092852924000087_r53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.296.1.47","article-title":"Varenicline, an \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial","volume":"296","author":"Gonzales","year":"2006","journal-title":"JAMA."},{"key":"S1092852924000087_r61","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1185\/03007990802177523","article-title":"The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial","volume":"24","author":"Niaura","year":"2008","journal-title":"Curr Med Res Opin."},{"key":"S1092852924000087_r69","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ntr\/nts146","article-title":"Varenicline to stop long-term nicotine replacement use: a double-blind, randomized, placebo-controlled trial","volume":"15","author":"Tonnesen","year":"2013","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r13","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1111\/add.13506","article-title":"Electronic cigarette use in the European Union: analysis of a representative sample of 27\u00a0460 Europeans from 28 countries","volume":"111","author":"Farsalinos","year":"2016","journal-title":"Addiction."},{"key":"S1092852924000087_r76","doi-asserted-by":"crossref","first-page":"h4052","DOI":"10.1136\/bmj.h4052","article-title":"Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis","volume":"351","author":"Li","year":"2015","journal-title":"BMJ."},{"key":"S1092852924000087_r93","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res."},{"key":"S1092852924000087_r97","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addbeh.2016.11.004","article-title":"The influence of sleep quality on smoking cessation in socioeconomically disadvantaged adults","volume":"66","author":"Peltier","year":"2017","journal-title":"Addict Behav."},{"key":"S1092852924000087_r85","first-page":"156","article-title":"Polysomnographic changes after varenicline administration for smoking cessation","volume":"5","author":"Pataka","year":"2019","journal-title":"ERJ Open Res."},{"key":"S1092852924000087_r41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/thx.2007.090647","article-title":"Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial","volume":"63","author":"Aubin","year":"2008","journal-title":"Thorax."},{"key":"S1092852924000087_r8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.2013.283787","article-title":"Pharmacological treatments for smoking cessation","volume":"311","author":"Cahill","year":"2014","journal-title":"JAMA"},{"key":"S1092852924000087_r6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.15585\/mmwr.mm6702a1","article-title":"Current cigarette smoking among adults \u2014 United States, 2016","volume":"67","author":"Jamal","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"S1092852924000087_r34","unstructured":"34. Medical Dictionary for Regulatory Activities Terminology (MedDRA) - Sleep disorders and disturbances - Classes | NCBO BioPortal [Internet]. https:\/\/bioportal.bioontology.org\/ontologies\/MEDDRA?p=classes&conceptid=http%3A%2F%2Fpurl.bioontology.org%2Fontology%2FMEDDRA%2F10040991. Accessed October 25, 2022."},{"key":"S1092852924000087_r95","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/16066359.2016.1190342","article-title":"Insomnia symptoms as a risk factor for cessation failure following smoking treatment","volume":"25","author":"Short","year":"2017","journal-title":"Addict Res Theory."},{"key":"S1092852924000087_r25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.smrv.2008.12.003","article-title":"Effects of nicotine on sleep during consumption, withdrawal and replacement therapy","volume":"13","author":"Jaehne","year":"2009","journal-title":"Sleep Med Rev."},{"key":"S1092852924000087_r33","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"S1092852924000087_r40","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet."},{"key":"S1092852924000087_r59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S2213-2600(14)70294-2","article-title":"Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial","volume":"3","author":"Lerman","year":"2015","journal-title":"Lancet Respir Med."},{"key":"S1092852924000087_r15","first-page":"CD010216","article-title":"Electronic cigarettes for smoking cessation","volume":"4","author":"Hartmann-Boyce","year":"2021","journal-title":"Cochrane Database Syst Rev."},{"key":"S1092852924000087_r38","unstructured":"38. Review Manager (RevMan) [Computer program]. Version 5.4. The Cochrane Collaboration, 2020."},{"key":"S1092852924000087_r75","doi-asserted-by":"crossref","first-page":"109312","DOI":"10.1016\/j.drugalcdep.2022.109312","article-title":"Evaluating the effectiveness of bupropion and varenicline for smoking cessation using an internet-based delivery system: a pragmatic randomized controlled trial (MATCH study)","volume":"232","author":"Zhang","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"S1092852924000087_r88","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.smrv.2007.12.004","article-title":"Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana","volume":"12","author":"Schierenbeck","year":"2008","journal-title":"Sleep Med Rev."},{"key":"S1092852924000087_r7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/ntr\/ntq067","article-title":"Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials","volume":"12","author":"Piper","year":"2010","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r56","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/jama.1994.03510320035026","article-title":"Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement","volume":"271","author":"Hurt","year":"1994","journal-title":"JAMA."},{"key":"S1092852924000087_r63","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archinte.166.15.1571","article-title":"Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation","volume":"166","author":"Oncken","year":"2006","journal-title":"Arch Intern Med."},{"key":"S1092852924000087_r31","doi-asserted-by":"crossref","first-page":"j3932","DOI":"10.1136\/bmj.j3932","article-title":"Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples","volume":"358","author":"Riley","year":"2017","journal-title":"BMJ."},{"key":"S1092852924000087_r49","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.280","article-title":"Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial","volume":"313","author":"Ebbert","year":"2015","journal-title":"JAMA."},{"key":"S1092852924000087_r70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1365-2796.2003.01185.x","article-title":"A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation","volume":"254","author":"Tonnesen","year":"2003","journal-title":"J Intern Med."},{"key":"S1092852924000087_r89","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00063198-200103000-00008","article-title":"Sleep in patients with asthma and chronic obstructive pulmonary disease","volume":"7","author":"Lewis","year":"2001","journal-title":"Curr Opin Pulm Med."},{"key":"S1092852924000087_r98","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.addbeh.2011.03.001","article-title":"Subjective sleep disturbance during a smoking cessation program: associations with relapse","volume":"36","author":"Okun","year":"2011","journal-title":"Addict Behav."},{"key":"S1092852924000087_r47","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/ntr\/ntw123","article-title":"Varenicline for smoking cessation in light smokers","volume":"18","author":"Ebbert","year":"2016","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r36","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"S1092852924000087_r96","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/ntr\/ntr179","article-title":"Predictors of short-term success in smoking cessation in relation to attendance at a smoking cessation program","volume":"13","author":"Dorner","year":"2011","journal-title":"Nicotine Tob Res."},{"key":"S1092852924000087_r92","first-page":"238","volume-title":"Insomnia: Psychological assessment and management","volume":"xvii","author":"Morin","year":"1993"},{"key":"S1092852924000087_r87","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1111\/acer.13217","article-title":"Alcohol dependence and its relationship with insomnia and other sleep disorders","volume":"40","author":"Chakravorty","year":"2016","journal-title":"Alcohol Clin Exp Res."},{"key":"S1092852924000087_r68","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archinte.1993.00410160041003","article-title":"Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling","volume":"153","author":"Sachs","year":"1993","journal-title":"Arch Intern Med."},{"key":"S1092852924000087_r80","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1006\/pmed.1996.0095","article-title":"Effects of 24-hr nicotine replacement on sleep and daytime activity during smoking cessation","volume":"25","author":"Wolter","year":"1996","journal-title":"Prev Med."},{"key":"S1092852924000087_r91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/archpsyc.1986.01800030107013","article-title":"Signs and symptoms of tobacco withdrawal","volume":"43","author":"Hughes","year":"1986","journal-title":"Arch Gen Psychiatry."},{"key":"S1092852924000087_r71","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.clinthera.2007.06.011","article-title":"A randomized, placebo-controlled trial of varenicline, a selective \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers","volume":"29","author":"Tsai","year":"2007","journal-title":"Clin Ther."},{"key":"S1092852924000087_r66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCULATIONAHA.109.869008","article-title":"Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease","volume":"121","author":"Rigotti","year":"2010","journal-title":"Circulation."},{"key":"S1092852924000087_r14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/tobaccocontrol-2017-053759","article-title":"Potential deaths averted in USA by replacing cigarettes with e-cigarettes","volume":"27","author":"Levy","year":"2018","journal-title":"Tob Control."},{"key":"S1092852924000087_r10","first-page":"CD006103","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"2016","author":"Cahill","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"S1092852924000087_r77","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1093\/eurheartj\/ehw048","article-title":"Outcomes and costs of left atrial appendage closure from randomized controlled trial and real-world experience relative to oral anticoagulation","volume":"37","author":"Panikker","year":"2016","journal-title":"Eur Heart J."},{"key":"S1092852924000087_r16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852924000087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T09:19:53Z","timestamp":1731575993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852924000087\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,4]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1092852924000087"],"URL":"https:\/\/doi.org\/10.1017\/s1092852924000087","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"type":"print","value":"1092-8529"},{"type":"electronic","value":"2165-6509"}],"subject":[],"published":{"date-parts":[[2024,3,4]]}}}